Induction outcome, differentiation syndrome frequency, and severity
| Characteristic . | Median (range) . | No. (%) . |
|---|---|---|
| Overall | 180* (100) | |
| Morphologic CR | 153 (85) | |
| Days to CR | 38 (14–151) | |
| Days to polymorphonuclear (PMN) cell count >1 × 109/L | 25 (5–50) | |
| Days to platelet counts >50 × 109/L | 22 (0–51) | |
| Symptoms/signs associated with DS | ||
| 0 | 138 (77) | |
| 1 | 6 (3) | |
| 2 | 15 (8) | |
| 3 | 16 (9) | |
| ≥4 | 5 (3) |
| Characteristic . | Median (range) . | No. (%) . |
|---|---|---|
| Overall | 180* (100) | |
| Morphologic CR | 153 (85) | |
| Days to CR | 38 (14–151) | |
| Days to polymorphonuclear (PMN) cell count >1 × 109/L | 25 (5–50) | |
| Days to platelet counts >50 × 109/L | 22 (0–51) | |
| Symptoms/signs associated with DS | ||
| 0 | 138 (77) | |
| 1 | 6 (3) | |
| 2 | 15 (8) | |
| 3 | 16 (9) | |
| ≥4 | 5 (3) |
Three patients who were lost to follow-up were excluded in the analysis of induction outcome.